Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Vulpe

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Molecular Cancer Therapeutics|April 21, 2026
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.
Environmental Health Perspectives|May 8, 2013
Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO ConsortiumTian Xia, Raymond F Hamilton, James C Bonner, et al.
Cancer Research|June 23, 2021
Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple MyelomaLenka Besse, Andrej Besse, Sara C Stolze, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Molecular Cancer Therapeutics|April 21, 2026
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.
Environmental Health Perspectives|May 8, 2013
Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO ConsortiumTian Xia, Raymond F Hamilton, James C Bonner, et al.
Cancer Research|June 23, 2021
Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple MyelomaLenka Besse, Andrej Besse, Sara C Stolze, et al.
Pageof 5